BioSpace News Archive

Some workers are more likely to experience depression according to Catapult Health analysis

International expert group focused on improving quality of clinical biomarker testing launching pilot TMB proficiency program in Spring 2019

Today, Atrium Health has announced that Vicki Block will be joining the organization as Senior Vice President, Central Division, leading facility operations for 3 key acute care facilities including Carolinas Medical Center, Carolinas Medical Center-Mercy and Levine Children’s Hospital. Block will officially join Atrium Health on April 1.

Abacus Health Products, Inc. (CSE: ABCS) (“Abacus” or the “Company”), the company offering CBDMEDIC™, the first family of topical medications combining active pharmaceutical ingredients with hemp extract and other natural moisturizers, has announced the national launch of 10 over-the-counter (OTC) pain relief products.

Synspira Therapeutics today announced the appointment of Robert Gallotto as President and Chief Executive Officer; he will also join the Board of Directors. Mr. Gallotto will succeed Shenda Baker, Ph.D., who served as interim Chief Executive Officer.

An AAAASF-accredited plastic surgery practice in Manhattan, NYC, bodySCULPT®, is pleased to announce that their plastic surgeons Dr Christopher T. Chia and Dr. Spero Theodorou will be teaching plastic surgeons from around the world live at the first ever Aston Baker Cutting Edge Global Aesthetic Symposium titled “It’s Just Surgery – Advanced Body Sculpting”.

AbleTo Inc., a leading provider of virtual behavioral health care, today announced its proprietary platform, EnAbleTo EHR, has earned Certified status for information security by HITRUST.

Army veteran Ramon Guandique moves independently, but has to manage his balance, memory, and chronic pain from injuries during military service that included Iraq deployments.

Bioventus, a global leader in orthobiologic solutions, is launching OSTEOAMP SELECT Fibers, an innovative addition to its allograft line of OSTEOAMP bone graft substitutes for spine, foot & ankle, orthopaedic, and trauma surgeons.

Enanta Pharmaceuticals, Inc. announced that new preclinical data from Enanta’s wholly-owned development programs for hepatitis B virus (HBV) and non-alcoholic steatohepatitis (NASH) have been accepted for presentations at The International Liver Congress™ (ILC) 2019, April 10-14, in Vienna, Austria.